-
1
-
-
0038179723
-
Cost of migration: Invasion of malignant gliomas and implications for treatment
-
Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol. 2003;21(8):1624-1636.
-
(2003)
J Clin Oncol
, vol.21
, Issue.8
, pp. 1624-1636
-
-
Giese, A.1
Bjerkvig, R.2
Berens, M.E.3
Westphal, M.4
-
2
-
-
79952740612
-
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
-
Keunen O, Johansson M, Oudin A, et al. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci USA. 2011;108(9):3749-3754.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, Issue.9
, pp. 3749-3754
-
-
Keunen, O.1
Johansson, M.2
Oudin, A.3
-
3
-
-
0035884609
-
Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2
-
Kunkel P, Ulbricht U, Bohlen P, et al. Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Res. 2001;61(18):6624-6628.
-
(2001)
Cancer Res
, vol.61
, Issue.18
, pp. 6624-6628
-
-
Kunkel, P.1
Ulbricht, U.2
Bohlen, P.3
-
4
-
-
84938578037
-
Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas
-
Fack F, Espedal H, Keunen O, et al. Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas. Acta Neuropathol. 2015;129(1):115-131.
-
(2015)
Acta Neuropathol
, vol.129
, Issue.1
, pp. 115-131
-
-
Fack, F.1
Espedal, H.2
Keunen, O.3
-
5
-
-
56349113871
-
CD133 is a marker of bioenergetic stress in human glioma
-
Griguer CE, Oliva CR, Gobin E, et al. CD133 is a marker of bioenergetic stress in human glioma. PLoS One. 2008;3(11):e3655.
-
(2008)
PLoS One
, vol.3
, Issue.11
, pp. e3655
-
-
Griguer, C.E.1
Oliva, C.R.2
Gobin, E.3
-
6
-
-
70350225829
-
The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype
-
Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle. 2009;8(20):3274-3284.
-
(2009)
Cell Cycle
, vol.8
, Issue.20
, pp. 3274-3284
-
-
Heddleston, J.M.1
Li, Z.2
McLendon, R.E.3
Hjelmeland, A.B.4
Rich, J.N.5
-
7
-
-
84888149337
-
Hypoxia and oxygenation induce a metabolic switch between pentose phosphate pathway and glycolysis in glioma stem-like cells
-
Kathagen A, Schulte A, Balcke G, et al. Hypoxia and oxygenation induce a metabolic switch between pentose phosphate pathway and glycolysis in glioma stem-like cells. Acta Neuropathol. 2013; 126(5):763-780.
-
(2013)
Acta Neuropathol
, vol.126
, Issue.5
, pp. 763-780
-
-
Kathagen, A.1
Schulte, A.2
Balcke, G.3
-
8
-
-
66249108601
-
Understanding the Warburg effect: The metabolic requirements of cell proliferation
-
Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029-1033.
-
(2009)
Science
, vol.324
, Issue.5930
, pp. 1029-1033
-
-
Vander Heiden, M.G.1
Cantley, L.C.2
Thompson, C.B.3
-
9
-
-
79851501293
-
A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target
-
Schulte A, Gunther HS, Phillips HS, et al. A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target. Glia. 2011;59(4):590-602.
-
(2011)
Glia
, vol.59
, Issue.4
, pp. 590-602
-
-
Schulte, A.1
Gunther, H.S.2
Phillips, H.S.3
-
10
-
-
0032982739
-
Ku70/ 80 gene expression and DNA-dependent protein kinase (DNA-PK) activity do not correlate with double-strand break (dsb) repair capacity and cellular radiosensitivity in normal human fibroblasts
-
Kasten U, Plottner N, Johansen J, Overgaard J, Dikomey E. Ku70/ 80 gene expression and DNA-dependent protein kinase (DNA-PK) activity do not correlate with double-strand break (dsb) repair capacity and cellular radiosensitivity in normal human fibroblasts. Br J Cancer. 1999;79(7-8):1037-1041.
-
(1999)
Br J Cancer
, vol.79
, Issue.7-8
, pp. 1037-1041
-
-
Kasten, U.1
Plottner, N.2
Johansen, J.3
Overgaard, J.4
Dikomey, E.5
-
11
-
-
0033081502
-
Isolation and culture of human neuromicrovascular endothelial cells for the study of angiogenesis in vitro
-
Lamszus K, Schmidt NO, Ergun S, Westphal M. Isolation and culture of human neuromicrovascular endothelial cells for the study of angiogenesis in vitro. J Neurosci Res. 1999;55(3): 370-381.
-
(1999)
J Neurosci Res
, vol.55
, Issue.3
, pp. 370-381
-
-
Lamszus, K.1
Schmidt, N.O.2
Ergun, S.3
Westphal, M.4
-
12
-
-
33750683969
-
A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo
-
Martens T, Schmidt NO, Eckerich C, et al. A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo. Clin Cancer Res. 2006;12(20 Pt 1):6144-6152.
-
(2006)
Clin Cancer Res
, vol.12
, Issue.20
, pp. 6144-6152
-
-
Martens, T.1
Schmidt, N.O.2
Eckerich, C.3
-
13
-
-
53049092916
-
Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2
-
Martens T, Laabs Y, Gunther HS, et al. Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2. Clin Cancer Res. 2008; 14(17):5447-5458.
-
(2008)
Clin Cancer Res
, vol.14
, Issue.17
, pp. 5447-5458
-
-
Martens, T.1
Laabs, Y.2
Gunther, H.S.3
-
14
-
-
84943237735
-
Inhibition of intracerebral glioblastoma growth by targeting the insulin-like growth factor 1 receptor involves different context-dependent mechanisms
-
Zamykal M, Martens T, Matschke J, et al. Inhibition of intracerebral glioblastoma growth by targeting the insulin-like growth factor 1 receptor involves different context-dependent mechanisms. Neuro Oncol. 2015;17(8):1076-1085.
-
(2015)
Neuro Oncol
, vol.17
, Issue.8
, pp. 1076-1085
-
-
Zamykal, M.1
Martens, T.2
Matschke, J.3
-
15
-
-
52949145307
-
Glycolytic enzyme inhibitors in cancer treatment
-
Scatena R, Bottoni P, Pontoglio A, Mastrototaro L, Giardina B. Glycolytic enzyme inhibitors in cancer treatment. Expert Opin Investig Drugs. 2008;17(10):1533-1545.
-
(2008)
Expert Opin Investig Drugs
, vol.17
, Issue.10
, pp. 1533-1545
-
-
Scatena, R.1
Bottoni, P.2
Pontoglio, A.3
Mastrototaro, L.4
Giardina, B.5
-
16
-
-
84955192227
-
The hypoxic tumor microenvironment: A driving force for breast cancer progression
-
Semenza GL. The hypoxic tumor microenvironment: A driving force for breast cancer progression. Biochim Biophys Acta. 2016; 1863(3):382-391.
-
(2016)
Biochim Biophys Acta
, vol.1863
, Issue.3
, pp. 382-391
-
-
Semenza, G.L.1
-
17
-
-
0842325802
-
Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population
-
Brat DJ, Castellano-Sanchez AA, Hunter SB, et al. Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res. 2004;64(3):920-927.
-
(2004)
Cancer Res
, vol.64
, Issue.3
, pp. 920-927
-
-
Brat, D.J.1
Castellano-Sanchez, A.A.2
Hunter, S.B.3
-
18
-
-
77954208220
-
A G{alpha}i-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate
-
Ghosh P, Beas AO, Bornheimer SJ, et al. A G{alpha}i-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate. Mol Biol Cell. 2010;21(13): 2338-2354.
-
(2010)
Mol Biol Cell
, vol.21
, Issue.13
, pp. 2338-2354
-
-
Ghosh, P.1
Beas, A.O.2
Bornheimer, S.J.3
-
19
-
-
77956790980
-
MicroRNA-451: A conditional switch controlling glioma cell proliferation and migration
-
Godlewski J, Bronisz A, Nowicki MO, Chiocca EA, Lawler S. microRNA-451: A conditional switch controlling glioma cell proliferation and migration. Cell Cycle. 2010;9(14):2742-2748.
-
(2010)
Cell Cycle
, vol.9
, Issue.14
, pp. 2742-2748
-
-
Godlewski, J.1
Bronisz, A.2
Nowicki, M.O.3
Chiocca, E.A.4
Lawler, S.5
-
20
-
-
84862762917
-
The go or grow potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase e and mediated by metabolic stress
-
Horing E, Harter PN, Seznec J, et al. The go or grow potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress. Acta Neuropathol. 2012;124(1):83-97.
-
(2012)
Acta Neuropathol
, vol.124
, Issue.1
, pp. 83-97
-
-
Horing, E.1
Harter, P.N.2
Seznec, J.3
-
21
-
-
84871191999
-
EphB2 receptor controls proliferation/ migration dichotomy of glioblastoma by interacting with focal adhesion kinase
-
Wang SD, Rath P, Lal B, et al. EphB2 receptor controls proliferation/ migration dichotomy of glioblastoma by interacting with focal adhesion kinase. Oncogene. 2012;31(50):5132-5143.
-
(2012)
Oncogene
, vol.31
, Issue.50
, pp. 5132-5143
-
-
Wang, S.D.1
Rath, P.2
Lal, B.3
-
22
-
-
14744296225
-
Proteomic characterization of harvested pseudopodia with differential gel electrophoresis and specific antibodies
-
Beckner ME, Chen X, An J, Day BW, Pollack IF. Proteomic characterization of harvested pseudopodia with differential gel electrophoresis and specific antibodies. Lab Invest. 2005;85(3): 316-327.
-
(2005)
Lab Invest
, vol.85
, Issue.3
, pp. 316-327
-
-
Beckner, M.E.1
Chen, X.2
An, J.3
Day, B.W.4
Pollack, I.F.5
-
23
-
-
0025701432
-
Glycolysis as primary energy source in tumor cell chemotaxis
-
Beckner ME, Stracke ML, Liotta LA, Schiffmann E. Glycolysis as primary energy source in tumor cell chemotaxis. J Natl Cancer Inst. 1990;82(23):1836-1840.
-
(1990)
J Natl Cancer Inst
, vol.82
, Issue.23
, pp. 1836-1840
-
-
Beckner, M.E.1
Stracke, M.L.2
Liotta, L.A.3
Schiffmann, E.4
-
24
-
-
84921410978
-
Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells
-
Shiraishi T, Verdone JE, Huang J, et al. Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells. Oncotarget. 2015;6(1):130-143.
-
(2015)
Oncotarget
, vol.6
, Issue.1
, pp. 130-143
-
-
Shiraishi, T.1
Verdone, J.E.2
Huang, J.3
-
25
-
-
79960029992
-
Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release
-
Goetze K, Walenta S, Ksiazkiewicz M, Kunz-Schughart LA, Mueller-Klieser W. Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release. Int J Oncol. 2011;39(2):453-463.
-
(2011)
Int J Oncol
, vol.39
, Issue.2
, pp. 453-463
-
-
Goetze, K.1
Walenta, S.2
Ksiazkiewicz, M.3
Kunz-Schughart, L.A.4
Mueller-Klieser, W.5
-
26
-
-
70349328536
-
The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase
-
Fairbank M, St-Pierre P, Nabi IR. The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase. Mol Biosyst. 2009; 5(8):793-801.
-
(2009)
Mol Biosyst
, vol.5
, Issue.8
, pp. 793-801
-
-
Fairbank, M.1
St-Pierre, P.2
Nabi, I.R.3
-
27
-
-
85029017231
-
Identification of the azole class of antifungals as potent inhibitors of hexokinase II mediated tumour metaboism in glioblastoma
-
Agnihotri S, Vartanian A, Burrell K, et al. Identification of the azole class of antifungals as potent inhibitors of hexokinase II mediated tumour metaboism in glioblastoma. Neuro Oncol. 2014; 16(suppl 5):v213.
-
(2014)
Neuro Oncol
, vol.16
, pp. v213
-
-
Agnihotri, S.1
Vartanian, A.2
Burrell, K.3
-
28
-
-
84881557242
-
Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer
-
Patra KC, Wang Q, Bhaskar PT, et al. Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. Cancer Cell. 2013;24(2): 213-228.
-
(2013)
Cancer Cell
, vol.24
, Issue.2
, pp. 213-228
-
-
Patra, K.C.1
Wang, Q.2
Bhaskar, P.T.3
|